Valsartan extended release - Ezra Innovations

Drug Profile

Valsartan extended release - Ezra Innovations

Alternative Names: EZR 104; valsartan XR

Latest Information Update: 14 Feb 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Ezra Pharma
  • Class Antihypertensives; Branched-chain amino acids; Small molecules; Tetrazoles
  • Mechanism of Action Angiotensin type 1 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Preregistration Heart failure; Hypertension

Most Recent Events

  • 14 Feb 2017 Chemical structure information added
  • 18 Jan 2017 Preregistration for Heart failure in USA (PO)
  • 18 Jan 2017 Preregistration for Hypertension in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top